Frova and Patanol drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Frova (frovatriptan succinate) and Patanol (olopatadine hydrochloride). Common drug interactions include headache among females.
The phase IV clinical study analyzes what interactions people have when they take Frova and Patanol. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.
What is Frova?
Frova has active ingredients of frovatriptan succinate. It is often used in migraine. eHealthMe is studying from 2,100 Frova users. Check the latest studies of Frova.
What is Patanol?
Patanol has active ingredients of olopatadine hydrochloride. It is often used in allergies. eHealthMe is studying from 5,339 Patanol users. Check the latest studies of Patanol.
11 people who take Frova and Patanol together, and have interactions are studied.
What are the common drug interactions of Frova and Patanol, by gender? *:
female:
- Headache (pain in head)
- Pain
- Panic attack
- Rash pruritic (redness with itching)
- Sinusitis (inflammation of sinus)
- Sluggishness (lacking alertness)
- Post procedural infection
- Tachycardia (a heart rate that exceeds the range of 100 beats/min)
- Weight increased
- Fungal infection
male:
n/a
What are the common drug interactions of Frova and Patanol, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Headache (pain in head)
- Pain
- Post procedural infection
- Tachycardia (a heart rate that exceeds the range of 100 beats/min)
- Weight increased
40-49:
n/a
50-59:
- Fungal infection
- Rash pruritic (redness with itching)
60+:
- Headache (pain in head)
What are the existing conditions these people have? *
- Immunodeficiency Common Variable: 5 people, 45.45%
- Postural Orthostatic Tachycardia Syndrome (abnormal increase in heart rate on becoming upright): 3 people, 27.27%
- Nausea (feeling of having an urge to vomit): 3 people, 27.27%
- Insomnia (sleeplessness): 3 people, 27.27%
- Hypersensitivity: 3 people, 27.27%
- Gastric Ph Decreased: 3 people, 27.27%
- Eye Allergy: 3 people, 27.27%
- Endometriosis (appearance of endometrial tissue outside the uterus and causing pelvic pain): 3 people, 27.27%
- Arrhythmias (irregular heartbeat): 3 people, 27.27%
- Apnea (temporary absence or cessation of breathing): 3 people, 27.27%
* Approximation only. Some reports may have incomplete information.
Do you take Frova and Patanol?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Frova and Patanol:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Frova:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Patanol:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Frova and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Patanol and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on frovatriptan succinate and olopatadine hydrochloride (the active ingredients of Frova and Patanol, respectively), and Frova and Patanol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Micro-K cause Malaise? - 8 seconds ago
- Occult Blood Positive and drugs of ingredients of chlorhexidine gluconate - 8 seconds ago
- Varices Oesophageal and drugs of ingredients of pantoprazole sodium - 20 seconds ago
- Nausea And Vomiting and drugs of ingredients of meprobamate - 22 seconds ago
- Could Esomeprazole Sodium cause Joint Pain? - 29 seconds ago
- Pain in Calcium Phosphate, how severe and when it was recovered? - 31 seconds ago
- Depakene vs. Topiramate, side effect and effectiveness comparison - 36 seconds ago
- Sinus Bradycardia and High Blood Pressure - 48 seconds ago
- Crohn'S Disease and Parkinson'S Disease - 52 seconds ago
- Purpura and drugs of ingredients of valdecoxib - 56 seconds ago